Cargando…

New Task Force Criteria Provide Evolution in Diagnosis of Arrhythmogenic Cardiomyopathy in Patients without Typical Progression of the Disease

Patient: Male, 41 Final Diagnosis: ARVC Symptoms: Recurrent palpitations and presyncope Medication: β blockers Clinical Procedure: CMRI • EP study • ICD implantation Specialty: Cardiology OBJECTIVE: Unusual clinical course BACKGROUND: The original Task Force Criteria from 1994 for the clinical diagn...

Descripción completa

Detalles Bibliográficos
Autores principales:	Parahuleva, Mariana S., Figiel, Jens, Ahrens, Holger, Schieffer, Bernhard, Divchev, Dimitar, Lüsebrink, Ulrich
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International Scientific Literature, Inc. 2017
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5375177/ https://www.ncbi.nlm.nih.gov/pubmed/28336907 http://dx.doi.org/10.12659/AJCR.901267

Ejemplares similares

Biventricular Unloading with Impella and Venoarterial Extracorporeal Membrane Oxygenation in Severe Refractory Cardiogenic Shock: Implications from the Combined Use of the Devices and Prognostic Risk Factors of Survival
por: Chatzis, Georgios, et al.
Publicado: (2021)

Comparison of Mechanical Support with Impella or Extracorporeal Life Support in Post-Cardiac Arrest Cardiogenic Shock: A Propensity Scoring Matching Analysis
por: Syntila, Styliani, et al.
Publicado: (2021)

Effect of the 2010 task force criteria on reclassification of cardiovascular magnetic resonance criteria for arrhythmogenic right ventricular cardiomyopathy
por: Liu, Ting, et al.
Publicado: (2014)

New-Onset Atrial Fibrillation in the Setting of COVID-19 Infection Is a Predictor of Mortality in Hospitalized Patients: CovAF-Study
por: Parahuleva, Mariana S., et al.
Publicado: (2023)

MRI in childhood Arrhythmogenic Right Ventricular Cardiomyopathy and proposed modification of the Task Force Criteria for children
por: Grosse-Wortmann, Lars, et al.
Publicado: (2012)

The secretory phospholipase A(2) group IIA: a missing link between inflammation, activated renin-angiotensin system, and atherogenesis?
por: Divchev, Dimitar, et al.
Publicado: (2008)

Comparison of mechanical circulatory support with venoarterial extracorporeal membrane oxygenation or Impella for patients with cardiogenic shock: a propensity-matched analysis
por: Karatolios, Konstantinos, et al.
Publicado: (2020)

Comparison of Mortality Risk Models in Patients with Postcardiac Arrest Cardiogenic Shock and Percutaneous Mechanical Circulatory Support
por: Chatzis, Georgios, et al.
Publicado: (2021)

Diagnosing arrhythmogenic right ventricular cardiomyopathy by 2010 Task Force Criteria: clinical performance and simplified practical implementation
por: Bosman, Laurens P, et al.
Publicado: (2020)

Towards automatic classification of cardiovascular magnetic resonance Task Force Criteria for diagnosis of arrhythmogenic right ventricular cardiomyopathy
por: Bourfiss, Mimount, et al.
Publicado: (2022)

Investigating the Accuracy of Quantitative Echocardiographic-Modified Task Force Criteria for Arrhythmogenic Ventricular Cardiomyopathy in Adolescent Male Elite Athletes
por: Sharma, Chetanya, et al.
Publicado: (2021)

Evolving Diagnostic Criteria for Arrhythmogenic Cardiomyopathy
por: Corrado, Domenico, et al.
Publicado: (2021)

Impact of new electrocardiographic criteria in arrhythmogenic cardiomyopathy
por: Hauer, Richard N. W., et al.
Publicado: (2012)

Treatment of Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia: An International Task Force Consensus Statement
por: Corrado, Domenico, et al.
Publicado: (2015)

Treatment of arrhythmogenic right ventricular cardiomyopathy/dysplasia: an international task force consensus statement
por: Corrado, Domenico, et al.
Publicado: (2015)

Left Ventricle Architecture and Valvular Integrity Following Microaxial Mechanical Support: A Two-Year Follow-Up Study
por: Chatzis, Georgios, et al.
Publicado: (2021)

Atomic Force Microscopy (AFM) Applications in Arrhythmogenic Cardiomyopathy
por: Peña, Brisa, et al.
Publicado: (2022)

Arrhythmogenic cardiomyopathy
por: Pilichou, Kalliopi, et al.
Publicado: (2016)

Arrhythmogenic right ventricular cardiomyopathy: evaluation of the current diagnostic criteria and differential diagnosis
por: Corrado, Domenico, et al.
Publicado: (2020)

The 2020 “Padua Criteria” for Diagnosis and Phenotype Characterization of Arrhythmogenic Cardiomyopathy in Clinical Practice
por: Graziano, Francesca, et al.
Publicado: (2022)

Arrhythmogenic Left Ventricular Cardiomyopathy: Genotype-Phenotype Correlations and New Diagnostic Criteria
por: Mattesi, Giulia, et al.
Publicado: (2021)

Pregnancy in arrhythmogenic cardiomyopathy
por: Wichter, Thomas, et al.
Publicado: (2021)

Scarring/arrhythmogenic cardiomyopathy
por: Corrado, Domenico, et al.
Publicado: (2023)

Hypertrophic, Dilated, and Arrhythmogenic Cardiomyopathy: Where Are We?
por: El Hadi, Hamza, et al.
Publicado: (2023)

The impact of new proposed arrhythmogenic right ventricular cardiomyopathy (ARVC) criteria on CMR diagnosis
por: Natale, Luigi, et al.
Publicado: (2013)

Analysis of Atrial Fibrillation Treatment Regimes in a Multicenter Cohort of Transcatheter Edge-to-Edge Mitral Valve Repair Patients
por: Waechter, Christian, et al.
Publicado: (2020)

Atypical Clinical Presentation of Arrhythmogenic Biventricular Cardiomyopathy
por: Rangel, Inês, et al.
Publicado: (2014)

Arrhythmogenic right ventricular cardiomyopathy
por: Cho, Yongkeun
Publicado: (2018)

Arrhythmogenic left ventricular cardiomyopathy
por: Mirmomen, Seyedeh Mojdeh, et al.
Publicado: (2020)

Natural History of Arrhythmogenic Cardiomyopathy
por: Mattesi, Giulia, et al.
Publicado: (2020)

Metabolic Signature of Arrhythmogenic Cardiomyopathy
por: Volani, Chiara, et al.
Publicado: (2021)

Arrhythmogenic left ventricular cardiomyopathy
por: Corrado, Domenico, et al.
Publicado: (2022)

What’s New in Arrhythmogenic Cardiomyopathies
por: Çimen, Tolga, et al.
Publicado: (2022)

Arrhythmogenic Right Ventricular Cardiomyopathy
por: Dolkar, Tsering, et al.
Publicado: (2022)

Expression of the Marburg I Single Nucleotide Polymorphism (MI-SNP) and the Marburg II Single Nucleotide Polymorphism (MII-SNP) of the Factor VII-Activating Protease (FSAP) Gene and Risk of Coronary Artery Disease (CAD): A Pilot Study in a Single Population
por: Parahuleva, Mariana S., et al.
Publicado: (2018)

Arrhythmogenic right ventricular cardiomyopathy/dysplasia on the basis of the revised diagnostic criteria in affected families with desmosomal mutations
por: Protonotarios, Nikos, et al.
Publicado: (2011)

Right Ventricular Cardiomyopathy Meeting the Arrhythmogenic Right Ventricular Dysplasia Revised Criteria? Don't Forget Sarcoidosis!
por: Vasaturo, Sabina, et al.
Publicado: (2015)

Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia
por: Indik, Julia H, et al.
Publicado: (2003)

Arrhythmogenic right ventricular cardiomyopathy/dysplasia
por: Thiene, Gaetano, et al.
Publicado: (2007)

Arrhythmogenic Cardiomyopathy: the Guilty Party in Adipogenesis
por: Stadiotti, Ilaria, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_hue76v78hnqla8jgo11oklsl6p